Siemens taps new VP of nuc med

Article

Markus Lusser has been named vice president of sales and marketing for the Siemens Medical Solutions' Nuclear Medicine Group. On March 1, he took over worldwide strategic sales and marketing planning for the division from Barbara Franciose. Lusser, who

Markus Lusser has been named vice president of sales and marketing for the Siemens Medical Solutions' Nuclear Medicine Group. On March 1, he took over worldwide strategic sales and marketing planning for the division from Barbara Franciose. Lusser, who joined Siemens in 1989, most recently served as CT segment manager in radiology for the U.S.

Recent Videos
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

Jeff Hall
March 14th 2025
Article

For immunocompromised individuals, denoised ultra-low-dose CT offers similar detail as normal-dose CT scans for pneumonia detection, according to a recent study.

The Reading Room: Potential fMRI Alternative -- fPACT

The Reading Room: Potential fMRI Alternative -- fPACT

Whitney J. Palmer
June 23rd 2021
Podcast

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

FDA Grants 510(k) Clearance for New Class of Photon-Counting CT Scanners

FDA Grants 510(k) Clearance for New Class of Photon-Counting CT Scanners

Jeff Hall
March 10th 2025
Article

The Naeotom Alpha class of photon-counting computed tomography (PCCT) scanners emphasize significantly reduced scan times and enhanced detection of small abnormalities.

The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19

The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19

Whitney J. Palmer
November 3rd 2020
Podcast

In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.

Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients

Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients

Jeff Hall
March 7th 2025
Article

The use of ivonescimab was correlated with a median 5.3-month improvement in progression-free survival (PFS) over pembrolizumab in patients with PD-L1 positive non-small cell lung cancer, according to CT and MRI findings from a phase 3 randomized multicenter trial.

What is the Best HCC Staging System for People Being Treated with Transarterial Chemoembolization (TACE)?

What is the Best HCC Staging System for People Being Treated with Transarterial Chemoembolization (TACE)?

Jeff Hall
March 5th 2025
Article

In a comparative study of staging systems for hepatocellular carcinoma, the Barcelona Clinic Liver Cancer (BCLC) system offered the highest likelihood ratio (LR) and lowest Akaike information criteria (AIC) for predicting overall survival after transarterial chemoembolization (TACE) for hepatocellular carcinoma.

© 2025 MJH Life Sciences

All rights reserved.